
Currently, testosterone is classified as a Schedule III controlled substance, the same schedule that restricts drugs like Ketamine and Tylenol with Codeine. This outdated classification stems from outdated and overblown concerns about misuse in athletics and performance enhancement, overlooking the legitimate medical needs of individuals with hormonal imbalances, and aging populations.
Medical professionals can prescribe other hormones, like estrogen or insulin, without the same unnecessary restrictions. Descheduling testosterone is crucial for reducing barriers to access and removing the stigma associated with its use in medical treatments. Many individuals who could benefit from testosterone therapy face unnecessary regulatory hurdles that delay or prevent them from receiving appropriate care.
Descheduling testosterone is key to improving patient access to treatments and promoting a more informed and compassionate approach to hormone therapy.
Benefits of Routine Testing: